Mesenchymal stromal cell derived endothelial progenitor treatment in patients with refractory angina

Abstract

The study demonstrated that it was safe to treat patients with stable CAD with autologous culture expanded MSC. Moreover, MSC treated patients had significant improvement in left ventricular function and exercise capacity, in addition to an improvement in clinical symptoms and SAQ evaluations.